{"id":8366,"date":"2026-02-20T19:43:23","date_gmt":"2026-02-20T19:43:23","guid":{"rendered":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/?page_id=8366"},"modified":"2026-04-10T21:12:39","modified_gmt":"2026-04-10T21:12:39","slug":"tajikistan","status":"publish","type":"page","link":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/grants\/tajikistan\/","title":{"rendered":"Tajikistan"},"content":{"rendered":"\n<p class=\"has-text-align-center is-style-text-callout\"><strong>Tajikistan<\/strong> is a Central Asian country with a population of approximately 10 million, with an estimated hepatitis C virus (HCV) prevalence of 3% and hepatitis B virus (HBV) prevalence of 5%.<\/p>\n\n\n\n<div class=\"wp-block-cover alignfull is-light\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-accent-1-background-color has-background-dim-100 has-background-dim\"><\/span><div class=\"wp-block-cover__inner-container is-layout-constrained wp-block-cover-is-layout-constrained\">\n<h2 class=\"wp-block-heading has-text-align-center is-style-heading-section\">Project Objectives<\/h2>\n\n\n\n<p class=\"is-style-text-callout\">This project aims to:<\/p>\n\n\n\n<ol class=\"wp-block-list has-text-callout-font-size\">\n<li>Demonstrate the simplicity and cost-effectiveness of rapid diagnostic tests (RDTs) for screening adults for HCV and HBV in both urban and rural settings.<\/li>\n\n\n\n<li>Train family doctors at local clinics to manage HCV- and HBV-positive patients without advanced liver disease.<\/li>\n\n\n\n<li>Simplify HCV testing and treatment protocols to improve linkage to care among newly diagnosed individuals.<\/li>\n\n\n\n<li>Collaborate with the Ministry of Health (MoH) to evaluate economic impact and implement a one-time nationwide adult screening program for HCV and HBV.<\/li>\n\n\n\n<li>Support government adoption of sustainable funding for testing and treatment, with the goal of eliminating HCV and HBV in Tajikistan by 2030.<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center is-style-heading-section\">Phase I (2026)<\/h2>\n\n\n\n<div class=\"wp-block-columns is-not-stacked-on-mobile is-layout-flex wp-block-columns-is-layout-flex\" style=\"margin-top:var(--wp--preset--spacing--heading)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80px\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2026\/04\/disease.svg\" alt=\"\" class=\"wp-image-8801\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading is-style-text-callout\" style=\"font-style:normal;font-weight:600\">Disease Burden and Budget Impact Analyses<\/h3>\n\n\n\n<p>CDA Foundation (CDAF) will collaborate with the MoH to estimate HCV and HBV prevalence across age groups, genders, and regions, and to assess the financial implications of a national elimination program.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-not-stacked-on-mobile is-layout-flex wp-block-columns-is-layout-flex\" style=\"margin-top:var(--wp--preset--spacing--heading)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80px\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2026\/04\/diagnostic.svg\" alt=\"\" class=\"wp-image-8806\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading is-style-text-callout\" style=\"font-style:normal;font-weight:600\">HCV Rapid Diagnostic Test (RDT) Donation<\/h3>\n\n\n\n<p>CDAF will donate 30,000 WHO-prequalified HCV RDTs and cover costs related to customs clearance and distribution to participating regions.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-not-stacked-on-mobile is-layout-flex wp-block-columns-is-layout-flex\" style=\"margin-top:var(--wp--preset--spacing--heading)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80px\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2026\/04\/training-nurses.svg\" alt=\"\" class=\"wp-image-8805\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading is-style-text-callout\" style=\"font-style:normal;font-weight:600\">Training of Nurses for HCV Screening<\/h3>\n\n\n\n<p>CDAF will fund and train master trainers who will visit participating polyclinics to train local nurses in administering HCV RDTs, recording results, and reporting data to the central government.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-not-stacked-on-mobile is-layout-flex wp-block-columns-is-layout-flex\" style=\"margin-top:var(--wp--preset--spacing--heading)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80px\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2026\/04\/training-doctors.svg\" alt=\"\" class=\"wp-image-8804\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading is-style-text-callout\" style=\"font-style:normal;font-weight:600\">Training of Family Doctors<\/h3>\n\n\n\n<p>CDAF, in partnership with the University of Maryland, has developed Russian-language training modules for general practitioners (GPs) to treat HCV. Based on the Ascend study in Washington, D.C., these modules demonstrate that trained GPs and nurses can achieve sustained virologic response (SVR) rates comparable to specialists. CDAF will support a train-the-trainer model to scale GP training nationwide.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-not-stacked-on-mobile is-layout-flex wp-block-columns-is-layout-flex\" style=\"margin-top:var(--wp--preset--spacing--heading)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80px\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2026\/04\/project-management.svg\" alt=\"\" class=\"wp-image-8803\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading is-style-text-callout\" style=\"font-style:normal;font-weight:600\">Project Management<\/h3>\n\n\n\n<p>CDAF will fund regional project managers to ensure screening targets are met and data is accurately reported to the central government.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-not-stacked-on-mobile is-layout-flex wp-block-columns-is-layout-flex\" style=\"margin-top:var(--wp--preset--spacing--heading)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80px\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2026\/04\/data-analysis.svg\" alt=\"\" class=\"wp-image-8802\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading is-style-text-callout\" style=\"font-style:normal;font-weight:600\">Data Analysis and Reporting<\/h3>\n\n\n\n<p>CDAF will conduct statistical analyses of screening data to determine HCV prevalence by age, gender, and region. These findings will inform updated disease burden and budget impact estimates to support national program funding.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-cover alignfull is-light\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-accent-1-background-color has-background-dim-100 has-background-dim\"><\/span><div class=\"wp-block-cover__inner-container is-layout-constrained wp-block-cover-is-layout-constrained\">\n<h2 class=\"wp-block-heading has-text-align-center is-style-heading-section\">Phase II (2027)<\/h2>\n\n\n\n<p class=\"has-text-align-center is-style-text-callout\">Phase II will replicate the Phase I model for hepatitis B, including testing, training, treatment, and data analysis.<\/p>\n<\/div><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center is-style-heading-section\">Funding<\/h2>\n\n\n\n<p class=\"has-text-align-center is-style-text-callout\">The project is co-funded equally by the Gilead Foundation and the CDA Foundation. The program is treatment-agnostic and does not require patients or the government to procure specific medications.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tajikistan is a Central Asian country with a population of approximately 10 million, with an estimated hepatitis C virus (HCV) prevalence of 3% and hepatitis B virus (HBV) prevalence of 5%. Phase I (2026) Disease Burden and Budget Impact Analyses CDA Foundation (CDAF) will collaborate with the MoH to estimate HCV and HBV prevalence across [&hellip;]<\/p>\n","protected":false},"author":939,"featured_media":0,"parent":6004,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"subtheme":[],"class_list":["post-8366","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/8366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/users\/939"}],"replies":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/comments?post=8366"}],"version-history":[{"count":5,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/8366\/revisions"}],"predecessor-version":[{"id":8809,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/8366\/revisions\/8809"}],"up":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/6004"}],"wp:attachment":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/media?parent=8366"}],"wp:term":[{"taxonomy":"subtheme","embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/subtheme?post=8366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}